Table 5.
Antiarrhythmic Medications Used With AF Ablation
| AF+HF (N=6072) | AF+HFrEF (N=2492) | PINNACLE AATAC Eligible Cohort (N=785) | |
|---|---|---|---|
| Amiodarone | 1005 (16.6%) | 566 (22.7%) | 195 (24.8%) |
| Dofetilide | 79 (1.3%) | 39 (1.6%) | 12 (1.5%) |
| Dronedarone | 136 (2.2%) | 42 (1.7%) | 10 (1.3%) |
| Flecainide | 24 (0.4%) | 1 (0.0%) | 0 (0.0%) |
| Propafenone | 22 (0.4%) | 4 (0.2%) | 1 (0.1%) |
| Quinidine | 1 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Sotalol | 84 (1.4%) | 43 (1.7%) | 19 (2.4%) |
AF indicates atrial fibrillation; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; PINNACLE, Practice Innovation and Clinical Excellence.